Cargando…
Optimizing antiviral therapy for COVID-19 with learned pathogenic model
COVID-19 together with variants have caused an unprecedented amount of mental and economic turmoil with ever increasing fatality and no proven therapies in sight. The healthcare industry is racing to find a cure with multitude of clinical trials underway to access the efficacy of repurposed antivira...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044392/ https://www.ncbi.nlm.nih.gov/pubmed/35477965 http://dx.doi.org/10.1038/s41598-022-10929-y |